DHR - Danaher Corp.
Close
269.31
2.290 0.850%
Share volume: 4,600,013
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$267.02
2.29
0.86%
Fundamental analysis
44%
Profitability
34%
Dept financing
37%
Liquidity
75%
Performance
48%
Performance
5 Days
-0.06%
1 Month
-2.14%
3 Months
6.67%
6 Months
5.55%
1 Year
2.40%
2 Year
-0.64%
Key data
Stock price
$269.31
DAY RANGE
$265.59 - $269.31
52 WEEK RANGE
$181.51 - $281.70
52 WEEK CHANGE
$0.02
DIVIDEND
$0.27
EX-DIVIDEND DATE
06/28/2024
NEXT EARNINGS DATE
10/29/2024
Company detail
CEO: Rainer Blair
Region: US
Website: https://www.danaher.com/
Employees: 79,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.danaher.com/
Employees: 79,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.
Recent news